Fundraising Fox

Oliver Sexton

Investor

Investment Director, Engineering Biology at UK Innovation & Science Seed Fund

London, England, United Kingdom

About

Oliver Sexton joined Midven in April 2014 to manage the UK Innovation & Science Seed Fund's engineering biology investments. He previously oversaw commercialisation of bioengineering and medical technologies at Imperial Innovations and served on the board of oncology company Acublate Ltd, with earlier commercial and partnering roles at Ark Therapeutics, biotech buy-side analysis, and pharma strategy consulting. He holds a BSc in Molecular Biology/Biotechnology and an MSc in Plant Science from Bristol University.

Invests in

BiotechDeep Tech

Experience

  1. Future Planet CapitalIC membercurrent2014 — present
  2. Future Planet CapitalInvestment Directorcurrent2014 — present
  3. CamGene TherapeuticsBoard Membercurrent2025 — present
  4. Ternary TherapeuticsBoard observercurrent2026 — presentLondon Area, United Kingdom
  5. HutanBioBoard Observercurrent2024 — present
  6. ikarovecDirectorcurrent2019 — present
  7. AntiverseBoard Observercurrent2021 — present
  8. twigBoard Observercurrent2022 — present
  9. Pencil Biosciences LimitedBoard Observercurrent2022 — present
  10. UK Innovation & Science Seed FundInvestment Directorcurrent2014 — presentLondon
  11. TropicInvestorcurrent2017 — present
  12. SOLASTA BioBoard Observercurrent2021 — present
  13. Imperial InnovationsHead Bio Engineering2010 — 2014

Skills & more

ExitsBoard of DirectorsMergers & Acquisitions (M&A)Investment AnalysisInvestment ComplianceFundraisingLicensingBoard DevelopmentBrand DevelopmentInvestmentsBiotechnologyVenture Capital
+7 moreLifesciencesCommercializationBusiness StrategyBiopharmaceuticalsStart-upsManagementPharmaceutical Industry
  • FCA Investment ManagerFinancial Conduct Authority

From Oliver's professional profile.

Investments

Board seats

Acublate Ltd

Per the firm's website.

Colleagues at UK Innovation & Science Seed Fund

Frequently asked questions

Who is Oliver Sexton?
Oliver Sexton joined Midven in April 2014 to manage the UK Innovation & Science Seed Fund's engineering biology investments. He previously oversaw commercialisation of bioengineering and medical technologies at Imperial Innovations and served on the board of oncology company Acublate Ltd, with earlier commercial and partnering roles at Ark Therapeutics, biotech buy-side analysis, and pharma strategy consulting. He holds a BSc in Molecular Biology/Biotechnology and an MSc in Plant Science from Bristol University.
Where does Oliver Sexton work?
Oliver Sexton is Investment Director, Engineering Biology at UK Innovation & Science Seed Fund.
What does Oliver Sexton invest in?
Oliver Sexton invests in Biotech, Deep Tech.
What boards does Oliver Sexton sit on?
Oliver Sexton holds tracked board seats at Acublate Ltd.
Where did Oliver Sexton go to school?
Oliver Sexton studied at University of Bristol (Molecular Biology); University of Nottingham (PhD: Bioremediation).

Same school

Shared employers